Your session is about to expire
← Back to Search
Opiophobia in Postsurgical Adults With Cancer
N/A
Recruiting
Led By Eileen Eileen, PHD,RN
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year.
Awards & highlights
No Placebo-Only Group
Summary
To learn how people who underwent surgery feel about their prescribed opioid medication after they leave the hospital.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 year.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
To explore the barriers and fears related to use of opioids among a population of adults who underwent surgery for cancer.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Opiophobia in Postsurgical AdultsExperimental Treatment3 Interventions
Participants that agree to take part in this study, partiicpants will have a virtual visit, via Zoom, about 7 days after you are discharged from the hospital. The visit will take about 20 minutes, and you will meet with a member of the research team to complete several questionnaires.
Find a Location
Who is running the clinical trial?
Sigma Theta Tau InternationalOTHER
3 Previous Clinical Trials
132 Total Patients Enrolled
M.D. Anderson Cancer CenterLead Sponsor
3,071 Previous Clinical Trials
1,803,180 Total Patients Enrolled
Eileen Eileen, PHD,RNPrincipal InvestigatorM.D. Anderson Cancer Center